May 16, 2016
Liver cancer is often deadly—less than 20% of patients survive five years—and it’s the leading cause of cancer-related deaths worldwide. And things aren’t getting better. Between the prevalence of hepatitis C and an escalating rate of obesity that leads to fatty liver disease and potentially cancer, new treatments are desperately needed for these cancer patients. Continue reading “Blocking RANTES may slow growth of liver cancer”
March 10, 2016
On March 17, SBP La Jolla is hosting a symposium on the interactions between the immune system and tumors, including how they can be leveraged for cancer treatment. The symposium is organized by Carl Ware, PhD and Robert Rickert, PhD, the directors of the Inflammatory and Infectious Disease Center and the Tumor Microenvironment and Cancer Immunology Program, respectively, and features presentations by leaders in the field:
Crystal Mackall, MD, Stanford University
Yang-Xin Fu, MD, PhD, UT Southwestern
Mikala Egeblad, PhD, Cold Spring Harbor Laboratory
Linda Bradley, PhD, Sanford Burnham Prebys Medical Discovery Institute
Jose Conejo-Garcia, MD, PhD, Wistar Institute
Jonathan Powell, MD, Johns Hopkins School of Medicine
Shannon Turley, PhD, Genentech
Karen Willard-Gallo, PhD, Institut Jules Bordet – Belgium
Sandip Patel, MD, UC San Diego
Adam Godzik, PhD, Sanford Burnham Prebys Medical Discovery Institute
The symposium will be held from 9-4:30 in Fishman Auditorium (overflow seating in the Building 12 auditorium), with a reception to follow. If you plan to attend, please register here.